Effects of Different Stiffness Settings During Robotic Isokinetic Training in Children With SMA
Official title: Effects of Different Stiffness Settings on Isokinetic Quadriceps Training in Children With Spinal Muscular Atrophy: A Randomized Within-Participant, Contralateral-Limb-Controlled Trial
Run by Peking University Third Hospital · NCT07822711 · Data updated 2026-11-12
This study tests whether a portable knee-training robot with a compliant vs. rigid stiffness setting improves knee strength in children with spinal muscular atrophy, using each child’s other leg as a comparison.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 6 Years to 12 Years |
| Sex | All |
| Enrollment | 13 (estimated) |
| Sponsor | Peking University Third Hospital Academic / other |
| Locations | 1 site (Beijing) |
| Status | Recruiting |
| Started | October 22, 2026 |
| Main results expected | January 15, 2027 |
| Study ends | January 30, 2027 |
| Registry record updated | October 23, 2026 |
| Trial ID | NCT07822711 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Children aged 6 to 12 years with spinal muscular atrophy who can sit independently and have stable disease-modifying treatment if applicable.
✕Probably not a fit
Children who cannot tolerate MRI/EMG, have uncontrolled blood pressure, or have other conditions limiting safe participation may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized, within-subject trial compares two stiffness settings (compliant and rigid) of a portable isokinetic knee training robot in children with spinal muscular atrophy. Each participant has one leg trained with the compliant setting and the other with the rigid setting, over up to 8 weeks with the same training volume. Primary outcome is the difference between settings in change from baseline for peak knee-extension torque, with secondary outcomes including range of motion, quadriceps size by MRI, femoral nerve conduction, and sit-to-stand performance. The study also monitors knee pain, skin temperature, fatigue, and other adverse events; enrollment targets at least 13 participants aged 6–12 years. Randomization uses sealed envelopes and the trial is open-label. Eligibility requires SMA diagnosis, age 6–12, ability to sit independently, and stable disease-modifying therapy if applicable.
Why it matters
Potential benefit: If successful, the approach could identify an optimal stiffness setting to maximize knee strength gains during robot-assisted training for children with SMA.
How similar studies have gone: Prior work with a portable robotic knee trainer in SMA has shown safety and measurable training effects, supporting exploration of stiffness as a modifiable factor.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Age 6 to 12 years. 2. Diagnosis of spinal muscular atrophy. 3. Able to maintain an independent seated position. 4. If receiving disease-modifying treatment, including nusinersen or risdiplam, the participant must have received a stable dose for at least 6 months before enrollment and must not change the treatment regimen during the study. Exclusion Criteria: 1. Any other major disease or medical condition that, in the investigator's judgment, would interfere with safe participation or interpretation of the study results. 2. The legal guardian declines to provide written informed consent, or the participant is unable to complete the study procedures. 3. Unable to undergo magnetic resonance imaging or electromyography and nerve conduction testing. 4. Blood pressure above the 95th percentile for age, sex, and height, as assessed by a clinician. 5. Lacks the cognitive capacity to understand or comply with the requirements of study participation.
Where it's running
-
Peking University Third Hospital
Beijing, China Recruiting
Study contacts
- Study coordinator: Fuzhen Yuan, Dr.
- Email: tildaren@163.com
- Phone: +8613111050197
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Newborn SMA Screening Service Evaluation
This project tests newborn SMA screening to see if it works well and is acceptable to families in the UK.
-
Biomarker search in SMA using advanced multi-omics
Researchers are trying to see if new biomarkers can help diagnose and monitor spinal muscular atrophy in patients and newborns.
-
Wearable monitoring of motor development in babies and young children with spinal muscular atrophy detected at birth
This project will try wearing small motion sensors at home to see if they can track how babies and young children diagnosed with spinal muscular atrophy at birth move and develop, compared with healthy children.
-
HABIT-ILE plus Functional Strength Training for Children with SMA
This study will try an intensive HABIT-ILE program combined with functional strength training for children aged 5–17 with SMA who are on stable disease-modifying therapy to see if it improves motor skills.
-
Long-read genetic analysis for Spinal Muscular Atrophy (LOREASI)
This project tries a long-read DNA technique on adults with known SMN1 copy-number patterns to find hidden '2+0' carrier genotypes that standard tests miss.
-
Portable markerless video system to measure walking in adults with neuromuscular conditions or healthy volunteers.
This project will test a portable video device that measures walking patterns to see if it can track gait changes in adults with neuromuscular diseases and in healthy volunteers.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.